CA2020663A1 - Analogues de substitution de magainin peptides - Google Patents

Analogues de substitution de magainin peptides

Info

Publication number
CA2020663A1
CA2020663A1 CA2020663A CA2020663A CA2020663A1 CA 2020663 A1 CA2020663 A1 CA 2020663A1 CA 2020663 A CA2020663 A CA 2020663A CA 2020663 A CA2020663 A CA 2020663A CA 2020663 A1 CA2020663 A1 CA 2020663A1
Authority
CA
Canada
Prior art keywords
analogues
magainin
substitution
amino acid
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2020663A
Other languages
English (en)
Other versions
CA2020663C (fr
Inventor
Richard A. Houghten
Julio H. Cuervo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2020663A1 publication Critical patent/CA2020663A1/fr
Application granted granted Critical
Publication of CA2020663C publication Critical patent/CA2020663C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002020663A 1989-07-07 1990-07-06 Analogues de substitution de magainin peptides Expired - Lifetime CA2020663C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37675489A 1989-07-07 1989-07-07
US376,754 1989-07-07

Publications (2)

Publication Number Publication Date
CA2020663A1 true CA2020663A1 (fr) 1991-01-08
CA2020663C CA2020663C (fr) 1999-12-07

Family

ID=23486335

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002020663A Expired - Lifetime CA2020663C (fr) 1989-07-07 1990-07-06 Analogues de substitution de magainin peptides

Country Status (16)

Country Link
EP (4) EP0437556B1 (fr)
JP (1) JP2854970B2 (fr)
CN (1) CN1055480C (fr)
AT (1) ATE146188T1 (fr)
AU (1) AU650236B2 (fr)
CA (1) CA2020663C (fr)
DE (1) DE69029377T2 (fr)
DK (1) DK0437556T3 (fr)
ES (1) ES2095255T3 (fr)
IE (1) IE63842B1 (fr)
IL (1) IL94939A (fr)
PH (4) PH30054A (fr)
PT (1) PT94625B (fr)
SG (1) SG47913A1 (fr)
WO (1) WO1991000869A1 (fr)
ZA (1) ZA905203B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114634553A (zh) * 2022-04-27 2022-06-17 贵州医科大学 阳离子肽c9及其应用

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000869A1 (fr) * 1989-07-07 1991-01-24 Scripps Clinic And Research Foundation Analogues de substitution des peptides de la magainine
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
WO1992022317A1 (fr) * 1991-06-12 1992-12-23 Magainin Pharmaceuticals, Inc. Composition de peptides biologiquement actifs presentant des substitutions au niveau de leur terminaison c et traitement a l'aide de ces peptides
US5424290A (en) * 1992-10-26 1995-06-13 Magainin Pharmaceuticals Inc. Biologically active peptides and uses therefor
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
CN101928340A (zh) * 2009-12-24 2010-12-29 深圳市圣西马生物技术有限公司 一组抗菌肽衍生物及其应用
CN104710523B (zh) * 2013-12-11 2017-12-29 华东理工大学 对铜绿假单胞菌具有抗菌性能的Magainin肽修饰物及其制备方法
KR20180022971A (ko) * 2015-07-02 2018-03-06 다나-파버 캔서 인스티튜트 인크. 안정화된 항미생물성 펩티드
WO2017151617A1 (fr) 2016-02-29 2017-09-08 Dana-Farber Cancer Institute, Inc. Peptides antimicrobiens agrafés à ciblage intracellulaire pour traiter une infection
CA3067047A1 (fr) * 2017-07-19 2019-01-24 Dana-Farber Cancer Institute, Inc. Peptides antimicrobiens stabilises pour le traitement d'infections bacteriennes resistantes aux antibiotiques
CN111892646B (zh) * 2020-08-13 2023-05-02 中国人民解放军军事科学院军事医学研究院 抗菌肽衍生物及其在制备抗细菌感染药物中的应用
CN112625092B (zh) * 2021-01-13 2023-03-28 兰州大学 一种基于polybia-MPI的抗菌多肽化合物及其合成与应用
CN120081951B (zh) * 2025-03-06 2025-09-30 辽宁波尔莱特农牧实业集团有限公司 一种抗菌肽Magainin 2-hEGF融合蛋白及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU609118B2 (en) * 1987-03-04 1991-04-26 United States of America, as represented by the Secretary, U.S. Department of Commerce, The New synthetic bioactive compounds and method of producing bioactive effect
US4810777A (en) 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
WO1991000869A1 (fr) * 1989-07-07 1991-01-24 Scripps Clinic And Research Foundation Analogues de substitution des peptides de la magainine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114634553A (zh) * 2022-04-27 2022-06-17 贵州医科大学 阳离子肽c9及其应用
CN114634553B (zh) * 2022-04-27 2024-03-08 贵州医科大学 阳离子肽c9及其应用

Also Published As

Publication number Publication date
ZA905203B (en) 1991-05-29
EP0751149A3 (fr) 1997-07-02
EP0437556B1 (fr) 1996-12-11
JP2854970B2 (ja) 1999-02-10
EP0437556A1 (fr) 1991-07-24
JPH04506801A (ja) 1992-11-26
AU650236B2 (en) 1994-06-16
ATE146188T1 (de) 1996-12-15
PH30054A (en) 1996-11-08
EP0751149A2 (fr) 1997-01-02
IE63842B1 (en) 1995-06-14
ES2095255T3 (es) 1997-02-16
PH30219A (en) 1997-02-05
DE69029377T2 (de) 1997-06-19
SG47913A1 (en) 1998-04-17
PT94625A (pt) 1991-03-20
IL94939A (en) 1996-12-05
DK0437556T3 (da) 1996-12-30
DE69029377D1 (de) 1997-01-23
CN1049166A (zh) 1991-02-13
IE902476A1 (en) 1991-02-13
CN1055480C (zh) 2000-08-16
AU5945490A (en) 1991-02-06
WO1991000869A1 (fr) 1991-01-24
EP0751148A3 (fr) 1997-07-02
CA2020663C (fr) 1999-12-07
EP0751148A2 (fr) 1997-01-02
PT94625B (pt) 1997-03-31
PH30218A (en) 1997-02-05
EP0761684A2 (fr) 1997-03-12
PH30410A (en) 1997-05-09
EP0437556A4 (en) 1992-05-20
IL94939A0 (en) 1991-06-10
EP0761684A3 (fr) 1997-07-02

Similar Documents

Publication Publication Date Title
CA2020663A1 (fr) Analogues de substitution de magainin peptides
AUPP051497A0 (en) Antimicrobial peptides
CA2100745A1 (fr) Peptides agonistes de l'amyline et leur utilisation
IE901696L (en) Fibronectin binding protein as well as its preparation
EP1440980A3 (fr) Analogues peptidiques de la protéine basique de la myéline humaine
EP0906919A3 (fr) Nouveaux peptides liant les intégrines
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
DE68905387D1 (de) Aminosaeure-nahrungsmittelzusammensetzungen.
CA2018714A1 (fr) Polypeptides hypothalamiques, agents stimulateurs de l'adenylate cyclase
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
KR0180256B1 (en) Bpc peptides, their preparation and use
WO1996028470A3 (fr) Analogues peptidiques de proteine de base de myeline utile dans le traitement de la sclerose en plaques
EP0334244A3 (fr) Peptides antagonistes de Bradykinine
CA2208274A1 (fr) Analogues de peptide p227 et compositions pharmaceutiques comprenant ces analogues utilisees dans le traitement ou le diagnostic du diabete
AU1691588A (en) A fibronectin binding protein as well as its preparation
EP0161007A3 (fr) Analogues de l'hexapeptide rétro-inverso C-terminal de la substance P
EP1006126A3 (fr) Peptide possedant une activité ostéogénique
SE9003374D0 (sv) A collagen binding protein as well as its preparation
CA2004885A1 (fr) Peptides anticoagulant
AU3494093A (en) S-lipophilic aliphatic carbonyl {n-mercaptoacyl-(amino acid or peptide)} compounds as antihypertensive agents
CA2171953A1 (fr) Analogues de regulateurs de proteines du complement d'activation
EP2143730A3 (fr) Peptides modifiés et leur utilisation pour le traitement des maladies auto-immunes
CA2078000A1 (fr) Peptides stimulateurs de neutrophile
GB2283974A (en) Allatostatins and their use
HU9303247D0 (en) Processfor producing 5-thia-1,4-diazabicyclo(4.2.0)octene-3,8-dioxo analogues of beta-lactame

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry